{
    "2019-03-27": [
        [
            {
                "time": "",
                "original_text": "大摩：升药明康德(02359.HK)目标价至123港元 业务表现指标均有改善",
                "features": {
                    "keywords": [
                        "药明康德",
                        "目标价",
                        "业务表现",
                        "改善"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德：业绩稳定高速增长，行业景气度持续提升",
                "features": {
                    "keywords": [
                        "药明康德",
                        "业绩",
                        "高速增长",
                        "行业景气度",
                        "提升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}